Back to search results

MATCHES: Colorectal Cancer and Hepatitis C Education and Screening

This study, called MATCHES, is testing an educational program to encourage screening for colorectal cancer (CRC) and Hepatitis C virus (HCV) among patients aged 45-75. You would complete a survey about your knowledge and beliefs regarding HCV and CRC, your intentions to get screened, and your background. Then, you would receive educational materials, like a booklet. The researchers want to see if this program increases the number of people who get screened for both conditions. You can join if you are 45-75 years old, receive care at a participating FQHC clinic, and are not up-to-date with your CRC screening (for example, no colonoscopy in the past 10 years). The study is currently unclear about its recruitment status and plans to enroll 350 participants.

Study design
This is an interventional study, meaning participants will receive an intervention. It aims to enroll 350 participants.
What's involved
Participants will complete a survey and receive educational intervention materials, such as a booklet.
Compensation
Not stated in the trial record.
Follow-up
Screening uptake for Hepatitis C Virus and Colorectal Cancer will be measured for up to 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06745895

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

Recruiting
NAAges 45–75InterventionalScreening
H. Lee Moffitt Cancer Center and Research Institute
~350 participants
Updated 2024-12-20 on ClinicalTrials.gov
What's tested:MATCHES

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Screening Uptake for Hepatitis C Virus (HCV) and Colorectal Cancer (CRC)
Measured over Up to 12 Months

Conditions

Colorectal Cancer Screening
Hepatitis C Virus

Explore related trials

Colorectal CarcinomaHepatitis C Infection

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Shannon Christy, PhD · PRINCIPAL_INVESTIGATOR · Moffitt Cancer Center
  • Clement K. Gwede, PhD, MPH, RN · PRINCIPAL_INVESTIGATOR · Moffitt Cancer Center

Who to contact

Carol Boxtha
[email protected]
813-745-8963
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants must be receiving care at one of the participating FQHC clinics.
Participants must be 45-75 years of age.
Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
Participants must never have had Hepatitis C Virus (HCV) antibody screening.
Participants must be able to read, write, and understand English or Spanish.
Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
Participants must be asymptomatic for HCV.
Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
Participants completing qualitative interviews must be willing to be audio recorded.
Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
All Participants must be able to provide informed consent.

Exclusion

Participants that do not meet all Inclusion Eligibility requirements will be excluded.

What this trial measures

  • Screening Uptake for Hepatitis C Virus (HCV) and Colorectal Cancer (CRC)Up to 12 Months

    Screening Uptake will be measured by the number of participants who complete both CRC and HCV screening documented via Electronic Health Record (EHR) at 12 months post-intervention.